Ullauri-Solórzano Vladimir E, Fierro Renoy Christian Humberto, Gaibor Barba Juan Carlos, Moreira-Vera Diana, Jaramillo Prado Henrry Oswaldo, Finke Barriga Ana Gabriela, Arias Adriano Víctor, Castro Vega Francisco Xavier, Chiliquinga Ana Cristina, Fonte Melendres Kateherine, Varela Pólit Luis Felipe, Chediak Pérez Estefanía, Arteaga Yépez Paulina Elizabeth, Paucar Rojas Luis Alberto, Izquierdo-Condoy Juan S, Vasconez-Gonzalez Jorge, Ortiz-Prado Esteban
Hospital Metropolitano de Quito, Quito 170521, Ecuador.
One Health Research Group, Universidad de las Americas, Quito 170137, Ecuador.
J Clin Med. 2025 Sep 3;14(17):6232. doi: 10.3390/jcm14176232.
Cardiovascular diseases (CVDs) are the leading global cause of death, responsible for 17.9 million deaths annually (32%) as of 2019. Acute coronary syndrome (ACS) significantly contributes to this burden, particularly in low- and middle-income countries. In Latin America, ACS accounts for 35% of deaths. In Ecuador, 36,058 deaths were reported between 2019 and 2021, underscoring its significant public health impact. This study aimed to determine the epidemiological, clinical, and hospital management characteristics of ACS patients admitted to the Metropolitan Hospital of Quito, located at high altitude, from January 2021 to October 2023. A retrospective observational study analyzed anonymized medical records of 133 ACS patients treated at a tertiary care hospital in Quito. Among 133 ACS patients, 72.9% were male, with a mean age of 68.9 ± 13.9 years. Overweight was prevalent, with a mean BMI of 26.6 ± 3.0 kg/m. Hypertension (51.9%) and type 2 diabetes mellitus (26.3%) were common comorbidities. ST-segment elevation myocardial infarction (STEMI) was the most frequent ACS type (48.9%), followed by non-ST-segment elevation myocardial infarction (NSTEMI) (33.8%). Most patients (72.2%) underwent stent placement. Mortality was low (2.3%) and significantly associated with the presence of immunologic diseases ( = 0.015), TIMI risk score Grade IV ( = 0.009), and cardiac arrest on admission ( < 0.001). This study provides critical insights into the epidemiology and management of ACS in a high-altitude urban setting, emphasizing the importance of timely diagnosis and evidence-based therapies in improving patient outcomes.
心血管疾病(CVDs)是全球主要的死亡原因,截至2019年,每年导致1790万人死亡(占32%)。急性冠状动脉综合征(ACS)对这一负担有显著影响,在低收入和中等收入国家尤为如此。在拉丁美洲,ACS占死亡人数的35%。在厄瓜多尔,2019年至2021年期间报告了36058例死亡病例,凸显了其对公共卫生的重大影响。本研究旨在确定2021年1月至2023年10月期间入住基多市大都会医院(位于高海拔地区)的ACS患者的流行病学、临床和医院管理特征。一项回顾性观察研究分析了基多一家三级护理医院治疗的133例ACS患者的匿名医疗记录。在133例ACS患者中,72.9%为男性,平均年龄为68.9±13.9岁。超重情况普遍,平均体重指数为26.6±3.0kg/m。高血压(51.9%)和2型糖尿病(26.3%)是常见的合并症。ST段抬高型心肌梗死(STEMI)是最常见的ACS类型(48.9%),其次是非ST段抬高型心肌梗死(NSTEMI)(33.8%)。大多数患者(72.2%)接受了支架置入术。死亡率较低(2.3%),且与免疫性疾病的存在(P=0.015)、TIMI风险评分IV级(P=0.009)和入院时心脏骤停(P<0.001)显著相关。本研究为高海拔城市环境中ACS的流行病学和管理提供了重要见解,强调了及时诊断和循证治疗对改善患者预后的重要性。